FDA-approved options like semaglutide and tirzepatide have strong safety profiles, but a healthcare provider must determine which is most appropriate for your body
It has been available longer than tirzepatide, which means more post-market surveillance data exists for patients with thyroid conditions
A: Because it stimulates your bodys natural pathways rather than shutting them down with synthetic hormones, long-term risks are considered low for healthy individuals
Duan L, Calhoun S, Shim D, Perez RE, Blatter LA, Maki CG
Therefore, targeted activation of antioxidant systems, especially the GSH system, is an essential treatment strategy to protect cardiomyocytes against oxidative damage